SCOTTSDALE, Ariz. — November 5, 2025 — Leads & Copy — Journey Medical Corporation (Nasdaq: DERM) will release its third quarter 2025 financial results after the U.S. financial markets close on Wednesday, November 12, 2025. Management will host a conference call and audio webcast on the same day at 4:30 p.m. ET.
Interested parties within the U.S. can listen to the conference call by dialing 1-866-777-2509 (domestic) or 1-412-317-5413 (international). Callers should dial in about 10 minutes prior to the start time and ask to join the Journey Medical conference call. Participants can register at https://dpregister.com/sreg/10204065/100324a2b1b.
A live audio webcast can be accessed on the News and Events page of the Investors section of Journey Medical’s website and will remain available for replay for about 30 days after the call.
Journey Medical Corporation (Nasdaq: DERM) focuses on selling and marketing FDA-approved prescription pharmaceutical products for dermatological conditions. The company currently markets eight branded FDA-approved prescription drugs that help treat and heal common skin conditions. Journey Medical was founded by Fortress Biotech, Inc. (Nasdaq: FBIO).
Contact:
Jaclyn Jaffe
Journey Medical Corporation
(781) 652-4500
ir@jmcderm.com
Media Relations Contact:
Tony Plohoros
6 Degrees
(908) 591-2839
tplohoros@6degreespr.com
Source: Journey Medical Corporation
